Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-07

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for Bupropion hydrochloride from Micro Labs Limited under ANDA207403, signaling regulatory approval of this generic form…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)